{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:16:38Z","timestamp":1792196198571,"version":"4.4.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Previous research has demonstrated that the hypoxic environment at high altitudes significantly alters the pharmacokinetics of many drugs, reducing their efficacy and increasing adverse effects. A key factor in this altered drug metabolism is the inhibition of ATP-binding cassette subfamily B member 1 (ABCB1), an efflux transporter protein, in the liver tissues of plateau rats. Rat ABCB1, encoded by the <jats:italic>ABCB1A<\/jats:italic> and <jats:italic>ABCB1B<\/jats:italic> genes, has two isoforms functionally analogous to human ABCB1. Histone acetylation, an epigenetic mechanism, may regulate ABCB1 transcription in hypoxic conditions by modifying chromatin structure and interacting with signaling pathways. However, its role in ABCB1 transcriptional regulation under hypoxia remains unclear. Based on this, the present study employed the BRL cell line to establish a hypoxia model, aiming to investigate the histone acetylation-mediated regulatory mechanisms of ABCB1 expression under hypoxic conditions, with the ultimate goal of providing novel theoretical foundations for rational drug use in high-altitude regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Establishment of BRL hypoxia model: BRL cell viability was detected by CCK-8 assay, and HIF-1\u03b1 expression was measured by RT-qPCR and Western blot. After treating the BRL hypoxia model with HDAC inhibitors, ABCB1 and HDAC5 expression were detected by RT-qPCR, Western blot, and immunofluorescence. Rhodamine 123 accumulation assay was performed to examine the effect of HDAC inhibitors on ABCB1 functional activity. HDAC5 was targeted by siRNA technology to detect ABCB1 and H3K9ac expression. CUT&amp;amp;Tag assay was used to measure H3K9ac levels at the ABCB1 promoter region. After SAHA treatment of the BRL hypoxia model, SP1 expression was detected by RT-qPCR and Western blot. Combined treatment with SAHA and siRNA targeting SP1 was performed to detect ABCB1 expression. Co-immunoprecipitation and fluorescence colocalization assays were conducted to examine interactions among SP1, HDAC5, and ABCB1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After hypoxic culture for different durations, cell viability decreased while HIF-1\u03b1 expression increased, indicating the successful establishment of the BRL hypoxia model. In the BRL hypoxia model, ABCB1 and SP1 expression decreased while HDAC5 expression increased. After SAHA treatment, ABCB1 and SP1 expression were upregulated while HDAC5 was downregulated. Rhodamine 123 accumulation assay showed that SAHA could enhance ABCB1 functional activity by inducing its expression. After HDAC5 was knocked down using siRNA, ABCB1 and H3K9ac expression increased, and ABCB1 functional activity was enhanced. CUT&amp;amp;Tag assay demonstrated that H3K9ac levels at the <jats:italic>ABCB1B<\/jats:italic> promoter region decreased in the BRL hypoxia model, while HDAC5 inhibition increased H3K9ac levels at this region. After SP1 was knocked down using siRNA, the inductive effect of SAHA on ABCB1 was blocked. Co-immunoprecipitation and fluorescence colocalization showed interactions among SP1, HDAC5, and ABCB1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In BRL cells, HDAC5 may be recruited by SP1 to form a complex, reducing free HDAC5, increasing H3K9ac at the <jats:italic>ABCB1B<\/jats:italic> promoter, and activating ABCB1 transcription. In the BRL hypoxia model, disruption of the SP1-HDAC5 complex increased free HDAC5, lowered H3K9ac at the <jats:italic>ABCB1B<\/jats:italic> promoter, and suppressed ABCB1 transcription. These results suggest that HDAC inhibitors enhance ABCB1 expression in hypoxic environments, indicating that combining HDAC inhibitors with therapeutic agents could mitigate reduced drug efficacy and adverse effects caused by ABCB1 suppression.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphys.2025.1520246","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:09:23Z","timestamp":1744096163000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulatory mechanism of ABCB1 transcriptional repression by HDAC5 in rat hepatocytes under hypoxic environment"],"prefix":"10.3389","volume":"16","author":[{"given":"Ziqin","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfang","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100645","DOI":"10.1016\/j.drup.2019.100645","article-title":"The multi-factorial nature of clinical multidrug resistance in cancer","volume":"46","author":"Assaraf","year":"2019","journal-title":"Drug Resist Updat"},{"key":"B2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1200\/JCO.21.01815","article-title":"Romidepsin plus CHOP versus CHOP in patients with previously untreated Peripheral T-cell lymphoma: results of the Ro-CHOP Phase III study (conducted by LYSA)","volume":"40","author":"Bachy","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"B3","first-page":"285","article-title":"The molecular mechanism of HDAC inhibitors in anticancer effects","volume":"3","author":"Bi","year":"2006","journal-title":"Cell Mol. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.pharmthera.2014.04.004","article-title":"Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights","volume":"143","author":"Bose","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1515\/hsz-2016-0307","article-title":"Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1","volume":"398","author":"Chen","year":"2017","journal-title":"Biol. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13402-016-0285-5","article-title":"Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers","volume":"39","author":"Chen","year":"2016","journal-title":"Cell Oncol. (Dordr)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2133\/dmpk.dmpk-13-sh-068","article-title":"Involvement of AP-1 and NF-\u03baB in the up-regulation of P-gp in vinblastine resistant Caco-2 cells","volume":"29","author":"Chen","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/BJ20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"De Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2217\/epi.15.106","article-title":"Regulation of class IIa HDAC activities: it is not only matter of subcellular localization","volume":"8","author":"Di Giorgio","year":"2016","journal-title":"Epigenomics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2174\/1381612825666190610140153","article-title":"Potential regulation mechanisms of P-gp in the Blood-brain Barrier in hypoxia","volume":"25","author":"Ding","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"B12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1124\/dmd.121.000681","article-title":"Exposure to high-altitude environment is associated with drug transporters change: microRNA-873-5p-mediated alteration of function and expression levels of drug transporters under hypoxia","volume":"50","author":"Duan","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"B13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/sj.bjc.6603914","article-title":"The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model","volume":"97","author":"El-Khoury","year":"2007","journal-title":"Br. J. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/38664","article-title":"Histone acetylation in chromatin structure and transcription","volume":"389","author":"Grunstein","year":"1997","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fphar.2018.00373","article-title":"Cloning and transcriptional activity analysis of the Porcine Abcb1 gene promoter: transcription factor Sp1 regulates the expression of Porcine Abcb1","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/diseases7040057","article-title":"Histone deacetylases and their inhibitors in cancer epigenetics","volume":"7","author":"Hassell","year":"2019","journal-title":"Diseases"},{"key":"B17","doi-asserted-by":"publisher","first-page":"101062","DOI":"10.1016\/j.molmet.2020.101062","article-title":"Histone deacetylase 5 regulates interleukin 6 secretion and insulin action in skeletal muscle","volume":"42","author":"Klymenko","year":"2020","journal-title":"Mol. Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"28061","DOI":"10.1074\/jbc.M414134200","article-title":"Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.16438\/j.0513-4870.2016-0344","article-title":"Changes of P-gp expression in rats\u2019 small intestine and effects on uptake of levofloxacin after acute exposure to hypoxia","volume":"51","author":"Li","year":"2016","journal-title":"Yao Xue Xue Bao"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/hep.26224","article-title":"Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1\u03b1 inhibition in hepatocellular carcinoma","volume":"57","author":"Liang","year":"2013","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1002\/ijc.32425","article-title":"Sp1-mediated epigenetic dysregulation dictates HDAC inhibitor susceptibility of HER2-overexpressing breast cancer","volume":"145","author":"Li","year":"2019","journal-title":"Int. J. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/03602532.2015.1007012","article-title":"MDR1 will play a key role in pharmacokinetic changes under hypoxia at high altitude and its potential regulatory networks","volume":"47","author":"Li","year":"2015","journal-title":"Drug Metab. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e51803","DOI":"10.15252\/embr.202051803","article-title":"The interplay between DNA and histone methylation: molecular mechanisms and disease implications","volume":"22","author":"Li","year":"2021","journal-title":"EMBO Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B25","first-page":"1169","article-title":"Effect of hypoxia on expressions of MDR1 and MRP2 in rats","volume":"36","author":"Luo","year":"2016","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"},{"key":"B26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/bdd.2154","article-title":"Evaluation of renal excretion and pharmacokinetics of furosemide in rats after acute exposure to high altitude at 4300 m","volume":"39","author":"Luo","year":"2018","journal-title":"Biopharm. Drug Dispos."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.biopha.2017.02.092","article-title":"Pharmacokinetic changes of norfloxacin based on expression of MRP2 after acute exposure to high altitude at 4300m","volume":"89","author":"Luo","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"109876","DOI":"10.1016\/j.cbi.2022.109876","article-title":"Synthesis, in vitro and structural aspects of cap substituted Suberoylanilide hydroxamic acid analogs as potential inducers of apoptosis in Glioblastoma cancer cells via HDAC\/microRNA regulation","volume":"357","author":"Mekala","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"B29","doi-asserted-by":"publisher","first-page":"119751","DOI":"10.1016\/j.bbamcr.2024.119751","article-title":"Akkermansia muciniphila ameliorates colonic injury in mice with DSS-induced acute colitis by blocking macrophage pro-inflammatory phenotype switching via the HDAC5\/DAB2 axis","volume":"1871","author":"Miao","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.13294\/j.aps.2018.0082","article-title":"Modulation of drug-metabolizing enzymes and transporters under hypoxia environment","volume":"71","author":"Min","year":"2019","journal-title":"Sheng Li Xue Bao"},{"key":"B31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3892\/ol.2014.2714","article-title":"HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review)","volume":"9","author":"Ni","year":"2015","journal-title":"Oncol. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41419-021-03497-y","article-title":"Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane","volume":"12","author":"Phatak","year":"2021","journal-title":"Cell Death Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"119504","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3892\/ol.2020.12011","article-title":"Effect of sodium butyrate on ABC transporters in lung cancer A549 and colorectal cancer HCT116 cells","volume":"20","author":"Shi","year":"2020","journal-title":"Oncol. Lett."},{"key":"B35","doi-asserted-by":"publisher","first-page":"103051","DOI":"10.1016\/j.jbc.2023.103051","article-title":"Expression of GnT-III decreases chemoresistance via negatively regulating P-glycoprotein expression: involvement of the TNFR2-NF-\u03baB signaling pathway","volume":"299","author":"Song","year":"2023","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","article-title":"Histone core modifications regulating nucleosome structure and dynamics","volume":"15","author":"Tessarz","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.tvjl.2013.10.022","article-title":"Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients","volume":"199","author":"Tomiyasu","year":"2014","journal-title":"Vet. J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3892\/ol.2019.10319","article-title":"Effects of histone deacetylase inhibitors on ATP-binding cassette transporters in lung cancer A549 and colorectal cancer HCT116 cells","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/ptr.7789","article-title":"Antimalarial activity and sensitization of chrysosplenetin against artemisinin-resistant genotype Plasmodium berghei K173 potentially via dual-mechanism of maintaining host P-glycoprotein homeostasis mediated by NF-\u03baB p52 or PXR\/CAR signaling pathways and regulating heme\/haemozoin metabolism","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370220944128","article-title":"Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications","volume":"246","author":"Wang","year":"2021","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.3390\/cancers13184700","article-title":"Vorinostat (SAHA) and breast cancer: an Overview","volume":"13","author":"Wawruszak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","article-title":"HDAC expression and clinical prognosis in human malignancies","volume":"280","author":"Weichert","year":"2009","journal-title":"Cancer Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.yexcr.2011.11.010","article-title":"Role for Class I histone deacetylases in multidrug resistance","volume":"318","author":"Xu","year":"2012","journal-title":"Exp. Cell Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.lfs.2018.11.043","article-title":"Histone deacetylase 2 regulates the doxorubicin (Dox) resistance of hepatocarcinoma cells and transcription of ABCB1","volume":"216","author":"Yang","year":"2019","journal-title":"Life Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: past, present and future","volume":"5","author":"Yoo","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"B47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/dmd.119.089953","article-title":"Epigenetic regulation of multidrug resistance protein 1 and breast cancer resistance protein transporters by histone deacetylase inhibition","volume":"48","author":"You","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.2174\/0929867328666211108105214","article-title":"Histone modifications and their role in epigenetics of cancer","volume":"29","author":"Zaib","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"755769","DOI":"10.3389\/fphys.2022.755769","article-title":"Changes in CYP3A4 enzyme expression and Biochemical markers under acute hypoxia affect the pharmacokinetics of sildenafil","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-15-8104-5_1","article-title":"Overview of histone modification","volume":"1283","author":"Zhang","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"B51","first-page":"1740","article-title":"Study on role of HDAC5 in ABCB1 expression in rats in high-altitude low oxygen environment and its effect on phenytoin sodium pharmacokinetics","volume":"39","author":"Zhao","year":"2023","journal-title":"Chin. Pharmacol. Bull."},{"key":"B52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/1389200224666230405115442","article-title":"Research Progress of epigenetic modification on the regulation of transporters under hypoxia","volume":"24","author":"Zhao","year":"2023","journal-title":"Curr. Drug Metab."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2025.1520246\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:09:37Z","timestamp":1744096177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2025.1520246\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":52,"alternative-id":["10.3389\/fphys.2025.1520246"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2025.1520246","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"article-number":"1520246"}}